Amphoteric hyaluronic acid derivative for targeting gene delivery

Biomaterials

Volumn 31, Issue 35, 2010, Pages 9357-9365

  Yao, Jing ^a   Fan, Ying ^a   Du, Ronghui ^b   Zhou, Jianping ^a   Lu, Yun ^a   Wang, Wei ^a   Ren, Jin ^a   Sun, Xiaojing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Hyaluronic acid; P53; Polyethyleneimine; Targeting gene delivery; Transfection

Indexed keywords

HYALURONIC ACIDS; P53; POLYETHYLENEIMINE; TARGETING GENE DELIVERY; TRANSFECTION;

COMPLEXATION; DNA; GENE THERAPY; GENE TRANSFER; ORGANIC ACIDS; TUMORS;

AGGLOMERATION;

AMPHOTERIC HYALURONIC ACID PLUS POLYETHYLENEIMINE; DNA; HYALURONIC ACID DERIVATIVE; LIPOFECTAMINE; NUCLEASE; PERIODATE; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL STRAIN HEPG2; CONTROLLED STUDY; DISSOCIATION; DNA DAMAGE; DNA REPAIR; GENE DELIVERY SYSTEM; GENE TARGETING; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL;

ANIMALS; DNA; GENE TRANSFER TECHNIQUES; HEP G2 CELLS; HUMANS; HYALURONIC ACID; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; POLYETHYLENEIMINE; TRANSFECTION;

EID: 77957935984     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.08.043     Document Type: Article

References (41)

1. Kim T.H., Ihm J.E., Choi Y.J., Nah J.W., Cho C.S. Efficiency gene delivery by urocanic acid-modified chitosan. J Control Release 2003, 93:389-402.
2. Felger P.L. Non-viral strategies for gene therapy. Sci Am 1997, 276:102-106.
3. Lungwitz U., Breunig M., Blunk T., Gopferich A. Polyethylenimine-based non-viral gene delivery systems. Eur J Pharm Biopharm 2005, 60:247-266.
4. Itaka K., Harada A., Yamasaki Y., Nakamura K., Kawaguchi H., Kataoka K. In situ single cell observation by fluorescence resonance energy transfer reveals fast intra-cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine. J Gene Med 2004, 6:76-84.
5. Clamme J.P., Azoulay J., Mely Y. Monitoring of the formation and dissociation of polyethylenimine/DNA complexes by two photon fluorescence correlation spectroscopy. Biophysical Journal 2003, 84:1960-1968.
6. Chollet P., Favrot M.C., Hurbin A., Coll J.L. Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J Gene Med 2002, 4:84-91.
7. Kurosaki T., Kitahara T., Fumoto S., Nishida K., Nakamura J., Niidome T., et al. Ternary complexes of pDNA, polyethylenimine, and γ-polyglutamic acid for gene delivery systems. Biomaterials 2009, 30:2846-2853.
8. Jiang G., Min S., Kim M., Lee D., Lim M., Yeom Y. Alginate/PEI/DNA polyplexes: a new gene delivery system. Yao Xue Xue Bao 2006, 41:439-445.
9. Ito T., Iida-Tanaka N., Niidome T., Kawano T., Kubo K., Yoshikawa K., et al. Hyaluronic acid and its derivative as a multi-functional gene expression enhancer: protection from non-specific interactions, adhesion to targeted cells, and transcriptional activation. J Control Release 2006, 112:382-388.
10. Ito T., Iida-Tanaka N., Koyama Y. Efficient in vivo gene transfection by stable DNA/PEI complexes coated by hyaluronic acid. J Drug Target 2008, 16:276-281.
11. Xu P., Quick G.K., Yeo Y. Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethylenimine. Biomaterials 2009, 30:5834-5843.
12. Abetamann V., Kern H.F., Elsasser H.P. Differential expression of the hyaluronan receptors CD44 andRHAMMin human pancreatic cancer cells. Clin Cancer Res 1996, 2:1607-1618.
13. Li H., Guo L., Li J.W., Liu N., Qi R., Liu J. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression. Int J Oncol 2000, 17:927-932.
14. Jiang G., Park K., Kim J., Kim K.S., Oh E.J., Kang H., et al. Hyaluronic acid -polyethyleneimine conjugate for target specific intracellular delivery of si RNA. Biopolymers 2008, 89:635-641.
15. Baneriji S., Wright A.J., Nobel M., Mahoney D.J., Cambell I.D., Day A.D., et al. Sturctures of the CD44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction. Nat Struct Mol Biol 2007, 14:234-239.
16. Bustin M., Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 1996, 54:35-100.
17. Jiang G., Park K., Kim J., Kim K.S., Hahn S.K. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis. Mol Pharmacol 2009, 6:727-737.
18. Pirollo K.F., Xu L., Chang E.H. Non-viral gene delivery for p53. Curr Opin Mol Ther 2000, 2:168-175.
19. Vold I.M., Christensen B.E. Periodate oxidation of chitosans with different chemical compositions. Carbohydr Res 2005, 340:679-684.
20. Sagara K., Kim S.W. A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes. J Control Release 2002, 79:271-281.
21. Petrak K. Polyelectrolyte complex. Polyelectrolytes: science and technology 1992, 265-297. Marcel Dekker, Inc., New York. M. Hara (Ed.).
22. Ling P.X. Hyaluronic acid 2007, Beijing. first ed.
23. Sun Y.X., Xiao W., Cheng S.X., Zhang X.Z., Zhuo R.X. Synthesis of (Dex-HMDI)-g-PEIs as effective and low cytotoxic nonviral gene vectors. J Control Release 2008, 128:171-178.
24. Kim T.G., Lee Y., Park T.G. Controlled gene-eluting metal stent fabricated by bio-inspired surface modification with hyaluronic acid and deposition of DNA/PEI polyplexes. Int J Pharm 2010, 384:181-188.
25. Jiang H.L., Kim Y.K., Arote R., Nah J.W., Cho M.H., Choi Y.J., et al. Chitosan-graft-polyethylenimine as a gene carrier. J Control Release 2007, 117:273-280.
26. Nimesh S., Goyal A., Pawar V., Jayaraman S., Kumar P., Chandra R., et al. Polyethylenimine nanoparticles as effiecient transfecting agents for mammalian cells. J Control Release 2006, 110:457-468.
27. McKee M.C., Lowenstein C.J., Horton M.R., Wu J., Chin B.Y., Choi A.M., et al. Hyaluronan fragments induce nitric-xide synthase in murine macrophages through a nuclear factor kappa B-dependent mechanism. J Biol Chem 1997, 272:8013-8018.
28. Zhou B., Weigel J.A., Fauss L., Weigel P.H. Identification of the hyaluronan receptor for endocytosis (HARE). J Biol Chem 2000, 275:37733-37741.
29. Pouyani T., Prestwich G.D. Functionalized derivatives of hyaluronic acid oligosaccharides: drug carriers and novel biomaterials. Bioconjug Chem 1994, 5:339-347.
30. Prestwich G.D., Marecak D.M., Marecek J.F., Vercruysse K.P., Ziebell M.R. Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives. J Control Release 1998, 53:93-103.
31. Ito T., Koyama Y., Otsuka M. Analysis of the surface structure of DNA/polycation/ hyaluronic acid ternary complex by Raman microscopy. J Pharm Biomed Anal 2010, 51:268-272.
32. Hornof M., Fuente M., Hallikainen M., Tammi R., Urtti A. Low molecular weight hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cells. J Gene Med 2008, 10:70-80.
33. Mammen M., Choi S., Whitesides G.M. Polvalent interactions in biological systems: implications for design and use of multivalent ligands and Inhibitors. Angew Chem Int Ed 1998, 37:2754-2794.
34. Eliaz R.E., Szoka F.C. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44- overexpressing tumor cells. Cancer Res 2001, 61:2592-2601.
35. Lesley J., Hascall V.C., Tammi M., Hyman R. Hyaluronan binding by cell surface CD44. J Biol Chem 2000, 275:26967-26975.
36. Liao Y.H., Jones S.A., Forbes B., Martin G.P., Brown M.B. Hyaluronan: pharmaceutical characterization and drug delivery. Drug Deliv 2005, 12:327-342.
37. Sheehan K.M., DeLott L.B., West R.A., Bonnema J.D., DeHeer D.H. Hyaluronic acid of high molecular weight inhibits proliferation and induces cell death in U937 macrophage cells. Life Sci 2004, 75:3087-3102.
38. Yao J., Zhou J.P., Ping Q.N., Lu Y., Chen L. Distribution of nobiletin chitosan-based microemulsion in brain following i.v. injection in mice. Int J Pharm 2008, 352:256-262.
39. Sadzuka Y., Nakade A., Hirama R., Miyagishima A., Nozawa Y., Hirota S., et al. Effect of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome. Int J Pharm 2002, 238:171-180.
40. Wolfert M.A., Dash P.R., Nazarova O., Oupicky D., Seymour L.W., Smart S., et al. Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA. Bioconjug Chem 1999, 10:993-1004.
41. Petersen H., Fechner P.M., Martin A.L., Kunath K., Stolnik S., Roberts C.J., et al. Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug Chem 2002, 13:845-854.